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ABSTRACT
Background Salvia divinorum is a non-water-soluble hallucinogen that is becoming increasingly popular among
adolescents. Salvia is a highly selective full agonist of primate and cloned human cerebral kappa-opioid receptors,
although its psychotomimetic effects are similar to serotonergic agonists and NMDA glutamate antagonists. Salvia has
been associated with depersonalization, laughter, feelings of levitation and self-consciousness. These effects resolve
within 30 minutes following use. Salvia has been banned in many countries, although it remains legal and easily
assessable over the internet in the United States. Case description A 15-year-old man with a history of salvia and
marijuana use presented to psychiatric emergency services with acute onset of mental status changes characterized by
paranoia, déjà vu, blunted affect, thought blocking and slow speech of 3 days’ duration. Conclusion There is limited
literature discussing the clinical effects of salvia use. Based on this case presentation, salvia use may be associated with
many undocumented long-term effects such as déjà vu. The ease of use and increasing popularity of salvia requires
further investigation into the clinical effects of salvia use.
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Mr M, a 15-year-old man, presented to the psychiatric
emergency services in May 2006 with an acute onset of
mental status changes characterized by paranoia, déjà
vu, blunted affect, thought blocking and slow speech of
3 days’ duration. He had no previous medical history, but
there was a family history of major depressive disorder in
his mother and brother, who required in-patient hospital-
ization. The parents described a period beginning in early
spring 2005, during which they became concerned about
an episode characterized by anhedonia, depressed mood,
declining academic performance and numerous absences
from school. During May 2005, the mother considered
seeking care from a psychologist for Mr M; however, his
mood had improved significantly by late June without
professional consultation. The temporal relationship of
the subsequent events was difficult to ascertain, because
the patient was a poor historian and resided on alternate
weeks with each of his divorced parents. In July 2005, Mr
M began using marijuana on a regular basis, along with
a one-time use of mushrooms, presumed to contain psilo-
cybin. In October, he placed an order online for Salvia
divinorum, which he then smoked on multiple occasions
over an unknown period of time. He described experienc-
ing visual hallucinations involving vivid colors and
objects when consuming salvia. When interviewed,
neither he nor his family were able to recall the last time
he engaged in the use of salvia. His family was able to
confirm the use of marijuana several hours before his
initial onset of paranoia 3 days prior to hospitalization.
Before this admission, except for the depressive symptoms
noted above, he had had no previous behavioral abnor-
malities noted by family and teachers.
During his hospitalization, he complained regularly of
déjà vu without other concurrent visual or auditory hal-
lucinations and paranoia towards those who informed
him that he had not previously experienced events or
conversations. His presentation was also notable for
mental slowing, with poor short-term memory, attention
and cognition. During his hospitalization all these symp-
toms improved significantly, although the feelings of déjà
vu remained. The differential diagnosis for the cause of
his déjà vu included salvia use, temporal lobe tumors or
temporal lobe seizures. A magnetic resonance imaging
(MRI) scan and electroecephalogram (EEG) obtained
upon consulting with neurology found no notable abnor-
malities. The absence of any abnormalities in these
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studies and improving mental status during hospitaliza-
tion were consistent with substance-induced mental
status changes. Because marijuana has not been docu-
mented to be a cause of déjà vu, salvia was considered the
most probable cause of déjà vu in Mr M.
S. divinorum, also known as magic mint or Diviner’s
Sage, was used by the shamans of Mazatec Indians in
Oaxaca, Mexico for ritualistic purposes [1]. Recently, it is
becoming an increasingly popular hallucinogen among
adolescents. At least six different compounds (salvinorin
A–F) have been extracted from the plant leaves with
salvinorin A (Divinorin A) being the most psychoactive
compound [2]. Salvinorin A is a non-water-soluble com-
pound that is absorbed primarily by the respiratory tract
and to a lesser extent by the oral mucosa when users
chew or smoke dried leaves [3]. Salvinorin A is a highly
selective full agonist of primate and cloned human cere-
bral kappa-opioid receptors, although its psychotomi-
metic effects are similar to serotonergic agonists (LSD)
and NMDA glutamate antagonists (PCP) [4,5]. This
association between psychotomimetic effects and kappa-
agonists has been documented with other substances
[6]. Users typically describe experiencing depersonaliza-
tion, hysterical laughter, transforming into people or
animals, being in multiple places at the same time, levi-
tation and increased sense of self-consciousness [7].
Users also indicate that these effects start within
5 minutes of consuming salvia and subside within
30 minutes [8]. Currently, there are no records of long-
term side effects of salvia use.
Although this substance is available easily over the
internet, it has been outlawed in Australia, Finland,
Denmark, Spain and Norway. Similar to our patient,
users are typically adolescent experimenters seeking a
safe method for meditative introspection. Analogous to
Bucheler et al.’s case report [1], our patient indicated that
he felt he was well informed, and he thought salvia was a
safe alternative to marijuana after reading websites citing
many scientific articles. Although Mr M perceived that
salvia’s drug safety was well studied, only three studies
and two case reports involving a total of 56 people discuss
the effects of salvia in human subjects. Bucheler notes
that the user may experience amnesia of the event, thus
potentially contributing to our patient’s inability to rec-
ollect his last use. As a non-water-soluble hallucinogen,
salvia could potentially have long-term consequences
associated with re-experiencing hallucinations or other
neuropsychiatric sequelae such as déjà vu. By being
accessible easily over the internet and becoming increas-
ingly popular among adolescents around the world,
salvia introduces a new substance about which health-
care workers should be informed, and the long-term
effects should be evaluated.
Informed consent by the patient was obtained prior to
publication of this case report.
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